Skip to main content
. 2021 Feb 23;13(2):202–209. doi: 10.1016/j.chmed.2021.02.001

Fig. 3.

Fig. 3

HDB treatment in db/db mice reduces fasting blood glucose. (A) Fasting blood glucose levels in the different treatment groups; (B) Body weight in the various treatment groups; (C) Oral glucose tolerance test (OGTT) after 4 weeks of treatment; (D) The area under the curve of OGTT; (E) Insulin tolerance test (ITT) after 4 weeks of treatment; (F) The area under the curve of ITT. #P < 0.05, ##P < 0.01 vs control group, *P < 0.05, **P < 0.01 vs model group.